<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322474</url>
  </required_header>
  <id_info>
    <org_study_id>8-5</org_study_id>
    <nct_id>NCT04322474</nct_id>
  </id_info>
  <brief_title>Russian National Registry of LAAO</brief_title>
  <official_title>Russian National Registry of Left Atrial Appendage Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Center for Preventive Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Medical Research Center for Therapy and Preventive Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first Russian registry presents data from two hundred consecutive patients with&#xD;
      nonvalvular atrial fibrillation, who undergone left atrial appendage occlusion (LAAO) using&#xD;
      the Watchman device and the Amplatzer cardiac plug. This government-funded catheter-based&#xD;
      LAAO program was started in September 2015 and was completed in December 2017. Data&#xD;
      collection was finished in December 2018. Five clinics agreed to participate in the study.&#xD;
&#xD;
      Patients' baseline characteristics, procedure, and follow up data were collected according to&#xD;
      established registry protocol. Patients were followed at 45 days, 3, 6 and 12 months after&#xD;
      enrollment. At each follow-up visit, the data regarding clinical events and healthcare&#xD;
      utilization was collected.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2015</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 30, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Procedure-related major adverse events (pericardial effusion, cardiac tamponade, device embolization, procedure/device-related death)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The composite of thromboembolic events, device thrombosis, hemorrhagic events, unexplained death</measure>
    <time_frame>12 months</time_frame>
    <description>Primary efficacy endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure success rate</measure>
    <time_frame>intraprocedural</time_frame>
    <description>successful left atrial appendage occluder implantation rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peridevice leakage</measure>
    <time_frame>6 months</time_frame>
    <description>incidence rates of significant (≥5mm) leakage</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Catheter-based left atrial appendage occlusion</intervention_name>
    <description>Catheter-based implantation of left atrial appendage occluder</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Nonvalvular atrial fibrillation patients with a high risk of thromboembolic and&#xD;
        haemorrhagic events&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥18 years nonvalvular atrial fibrillation,&#xD;
&#xD;
          -  CHA2DS2VASc ≥2,&#xD;
&#xD;
          -  high risk of hemorrhagic events,&#xD;
&#xD;
          -  non-compliance with pharmacological anticoagulant therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant mitral valve disease,&#xD;
&#xD;
          -  left ventricular ejection fraction &lt;35%,&#xD;
&#xD;
          -  the tendency to systemic thrombosis,&#xD;
&#xD;
          -  severe co-morbidities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karapet Davtyan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Research Center for Preventive Medicine</affiliation>
  </overall_official>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>left atrial appendage</keyword>
  <keyword>stroke prevention</keyword>
  <keyword>occluder</keyword>
  <keyword>Watchman device</keyword>
  <keyword>Amplatzer Cardiac Plug</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

